A pharmaceutical corporation investigating new therapeutic age | USMLE Biochemistry Videos & Books

A pharmaceutical corporation investigating new therapeutic agents for treatment of Burkitt lymphoma
synthesizes a double-stranded RNA molecule that is 21 base pairs in length. The RNA molecule has a base pair sequence that is complementary to a region of mRNA encoding c-Myc. Introduction of the RNA molecule into tumor cells results in a significant reduction in cell growth. Western blot analysis of equivalent numbers of treated and untreated cells is shown below.